2018 annual financial data
Marker Therapeutics 2018 Financial results
Direct answer
Revenue was 205,994 USD.
Operating income was -148,172,000 USD and net income was -147,958,000 USD.
Operating cash flow was -14,479,916 USD.
Get free Marker Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 205,994 USD
- Operating income
- -148,172,000 USD
- Net income
- -147,958,000 USD
- Operating cash flow
- -14,479,916 USD
Explore related company data
View all 2018 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Marker Therapeutics financial years